U
XTL Biopharmaceuticals Ltd. XTLB
$1.25 -$0.08-6.02% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
--
EPS (TTM)

12/31/2024 12/31/2023 09/30/2023 06/30/2023 03/31/2023
Revenue -- -- -- -- --
Total Other Revenue -- -- -- -- --
Total Revenue -- -- -- -- --
Cost of Revenue -- -- -- -- --
Gross Profit -- -- -- -- --
SG&A Expenses -- 734.00K 759.00K 815.00K 845.00K
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses -- 765.00K 790.00K 843.00K 882.00K
Operating Income -- -765.00K -790.00K -843.00K -882.00K
Income Before Tax -- -1.78M -2.25M -2.85M -2.77M
Income Tax Expenses -- -- -- -- --
Earnings from Continuing Operations -- -1.78 -2.25 -2.85 -2.77
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income -- -1.78M -2.25M -2.85M -2.77M
EBIT -- -765.00K -790.00K -843.00K -882.00K
EBITDA -- -764.20K -789.20K -842.20K -881.20K
EPS Basic -- 0.00 0.00 -0.01 -0.01
Normalized Basic EPS -- 0.00 0.00 0.00 0.00
EPS Diluted -- 0.00 0.00 -0.01 -0.01
Normalized Diluted EPS -- 0.00 0.00 0.00 0.00
Average Basic Shares Outstanding -- 2.18B 2.18B 2.18B 2.18B
Average Diluted Shares Outstanding -- 2.18B 2.18B 2.18B 2.18B
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --